ORAOV1 antibody (Internal Region)
ORAOV1
Reactivity: Human
WB, ELISA, IF, IHC
Host: Rabbit
Polyclonal
unconjugated
-
-
Target
See all ORAOV1 products
-
ORAOV1
(Oral Cancer Overexpressed 1 (ORAOV1))
-
Binding Specificity
-
Internal Region
-
Reactivity
-
Human
-
Host
-
Rabbit
-
Clonality
-
Polyclonal
-
Conjugate
-
This ORAOV1 antibody is un-conjugated
-
Application
-
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC)
-
Cross-Reactivity
-
Human
-
Purification
-
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
-
Synthesized peptide derived from the Internal region of Human ORAOV1.
-
Isotype
-
IgG
-
-
-
Application Notes
-
WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000,
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
-
Sodium azide
-
Precaution of Use
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
-
-20 °C,-80 °C
-
Storage Comment
-
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
Target
-
ORAOV1
(Oral Cancer Overexpressed 1 (ORAOV1))
-
Alternative Name
-
ORAOV1 (ORAOV1 Products)
-
Synonyms
-
TAOS1 antibody, 2210010N10Rik antibody, oral cancer overexpressed 1 antibody, ORAOV1 antibody, Oraov1 antibody
-
Background
-
LTO1 antibody, ORAOV1 antibody, TAOS1Protein LTO1 homolog antibody, Oral cancer-overexpressed protein 1 antibody, Tumor-amplified and overexpressed sequence 1 antibody
-
UniProt
-
Q8WV07
-